| 663 |
Centers for Disease Control and Prevention |
Html |
en |
Bidis and Kreteks - Smoking & Tobacco Use |
Tobacco Industry and Products Fact Sheets. |
| Mortality Weekly Report | 0.736921 |
| reduced oxygen absorption | 0.46092 |
| nicotine addiction | 0.411423 |
| Tobacco Control Act | 0.611152 |
| conventional cigarettes | 0.418918 |
| lung cancer | 0.437099 |
| Disease Control | 0.52913 |
| oral cancer | 0.475271 |
| Yusuf S. Risk | 0.466429 |
| World Health Organization | 0.621106 |
| Clove Cigarette Smoking | 0.537694 |
| Occupational Lung Diseases | 0.462932 |
| Risk Factors | 0.459423 |
| High School Students—United | 0.725188 |
| carbon monoxide | 0.489706 |
| bidi smoking | 0.968962 |
| Bidi Cigarettes | 0.670044 |
| long-term health effects | 0.643066 |
| Nov | 0.624469 |
| Southeast Asian countries | 0.48994 |
| International Journal | 0.447961 |
| combustible tobacco product | 0.517574 |
| Family Smoking Prevention | 0.536764 |
| U.S. middle school | 0.485032 |
|
| Fukui T. Bidi | 0.800783 |
| acute lung injury | 0.49234 |
| S. Bidi Smoking | 0.684593 |
| Bidi Cigarette | 0.568238 |
| United States.1,3,5,6 | 0.410967 |
| hand-rolled cigarettes | 0.426767 |
| flavored cigarettes | 0.412101 |
| Regular kretek smokers | 0.474755 |
| School Students—United States | 0.723091 |
| Tobacco Research. | 0.423906 |
| Carbon Monoxide Yields | 0.459948 |
| high school students | 0.481784 |
| kretek smoking | 0.511201 |
| middle school males | 0.485466 |
| lung problems | 0.415878 |
| T. Bidi Smoking | 0.835199 |
| bidis | 0.515884 |
| relative standard error | 0.459828 |
| stomach cancer | 0.412786 |
| low prevalence | 0.490352 |
| research studies | 0.48493 |
| coronary heart disease | 0.477084 |
| adverse health conditions | 0.496028 |
| abnormal lung function | 0.489677 |
|
CLICK HERE |
| 992 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: A Cluster of LymphocyticChoriomeningitis Virus Infections Transmitted Through OrganTransplantation - Iowa, 2013 |
Ilana J. Schafer, DVM1, Rachel Miller, MD2, Ute Ströher, PhD3, Barbara Knust, DVM3, Stuart T. Nichol, PhD3, Pierre E. |
| CDC | 0.757274 |
| mental status | 0.719175 |
| mild memory deficits | 0.814435 |
| public health practitioners | 0.795062 |
| Human Services | 0.785501 |
| immunoglobulin M. Patient | 0.859371 |
| MMWR HTML versions | 0.793484 |
| U.S. Department | 0.782906 |
| rodent exposure | 0.819648 |
| Organ Sharing | 0.816741 |
| organ transplantation | 0.89541 |
| oral ribavirin | 0.881817 |
| electronic PDF version | 0.795955 |
| prompt treatment initiation | 0.798038 |
| lymphocytic choriomeningitis virus | 0.832608 |
| LCMV-infected organ recipients | 0.933902 |
| large intracerebral hemorrhage | 0.844404 |
| early posttransplant period | 0.796513 |
| allograft failure | 0.712583 |
| Contact GPO | 0.719617 |
| organ transplant recipients | 0.989377 |
| transcription–polymerase chain reaction | 0.810411 |
| nontransplanted donor organs | 0.844486 |
| LCMV infections | 0.821141 |
|
| respiratory compromise | 0.716239 |
| original paper copy | 0.788648 |
| causative agent | 0.719132 |
| previous cornea recipients | 0.867208 |
| right kidney | 0.716729 |
| Diagnostic testing | 0.719774 |
| ill recipients | 0.856017 |
| original MMWR paper | 0.8013 |
| U.S. Government Printing | 0.796838 |
| blood samples | 0.716659 |
| aortic endothelial cells | 0.813912 |
| multiple recipients | 0.763598 |
| influenza-like illness | 0.722587 |
| critical condition | 0.718147 |
| United Network | 0.729508 |
| intravenous ribavirin treatment | 0.916692 |
| common organ donor | 0.968628 |
| life-threatening disease | 0.726203 |
| intravenous immunoglobulin | 0.744662 |
| rodent-borne virus | 0.721405 |
| organ donors | 0.777923 |
| organ transplant-associated cluster | 0.882185 |
| occasional aseptic meningitis | 0.834182 |
| intracranial hemorrhage | 0.725978 |
|
CLICK HERE |
| 1228 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: National Cleft and Craniofacial Awareness andPrevention Month - July 2014 |
July is National Cleft and Craniofacial Awareness and Prevention Month, an observance intended to raise awareness and improve understanding of birth defects of the head and face. Common craniofacial birth defects include orofacial clefts (cleft lip, cleft palate, or both), craniosynostosis (when the skull sutures join together prematurely), and anotia/microtia (when the ear is missing or malformed). |
| endorsement | 0.335722 |
| observance | 0.315731 |
| early pregnancy | 0.518575 |
| Human Services | 0.435515 |
| National Birth Defects | 0.505111 |
| MMWR HTML versions | 0.439902 |
| U.S. Department | 0.433084 |
| Craniofacial Awareness | 0.485507 |
| cleft lip | 0.426358 |
| craniofacial birth defects | 0.553952 |
| electronic PDF version | 0.434405 |
| understanding | 0.314994 |
| Canfield MA | 0.383384 |
| Additional information | 0.381057 |
| CDC highlights research | 0.479445 |
| Contact GPO | 0.391041 |
| commercial sources | 0.378198 |
| current prices | 0.37505 |
| original paper copy | 0.438151 |
| Prevention Network | 0.381141 |
| et al. | 0.377531 |
| women | 0.326824 |
| United States | 0.459217 |
| U.S. Government Printing | 0.441316 |
|
| original MMWR paper | 0.437148 |
| orofacial clefts | 0.901943 |
| national birth prevalence | 0.461539 |
| National Cleft | 0.492743 |
| babies | 0.329587 |
| Parker SE | 0.37734 |
| MMWR readers | 0.380295 |
| character translation | 0.374276 |
| Mai CT | 0.378586 |
| head | 0.314972 |
| Health-care providers | 0.385215 |
| skull sutures | 0.39852 |
| maternal smoking | 0.391267 |
| Clin Mol Teratol | 0.454893 |
| format errors | 0.37474 |
| craniosynostosis | 0.319431 |
| typeset documents | 0.378119 |
| cleft palate | 0.427782 |
| trade names | 0.378257 |
| official text | 0.37334 |
| birth defects | 0.702291 |
| Surgeon General | 0.382884 |
| non-CDC sites | 0.376907 |
| electronic conversions | 0.372745 |
|
CLICK HERE |
| 5752 |
Centers for Disease Control and Prevention |
Html |
en |
Methyl formate - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6898 |
Centers for Disease Control and Prevention |
Html |
en |
Rabies Risk Assessment of Exposures to a Bat on a Commercial Airliner - United States, August 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| risk assessment | 0.734352 |
| bat saliva | 0.455304 |
| commercial airliner | 0.500532 |
| early morning flight | 0.469719 |
| rabies virus transmission | 0.550916 |
| bat | 0.688891 |
| Public Health Madison | 0.521852 |
| Zoonotic Infectious Diseases | 0.512782 |
| risk assessment tool | 0.590371 |
| flight crew | 0.582539 |
| potential bat contact | 0.540223 |
| passengers | 0.798755 |
| rabies diagnostic testing | 0.539829 |
| public health precaution | 0.443801 |
| public health officials | 0.646357 |
| rabies virus variants | 0.640596 |
| rabies transmission | 0.539534 |
| bat sightings | 0.500149 |
| airport | 0.473698 |
| Airport Environmental Assessment | 0.456851 |
| environmental assessment | 0.475763 |
| Dane County | 0.456612 |
| previous bat sightings | 0.495286 |
| rabies status | 0.520158 |
|
| commercial airline flight | 0.454758 |
| rabies virus | 0.91107 |
| flight | 0.635442 |
| airline passengers increases | 0.525045 |
| United States | 0.524564 |
| bat capture | 0.442359 |
| human rabies | 0.645787 |
| bats | 0.528067 |
| unidentified passengers | 0.487164 |
| Immunization Practices | 0.486623 |
| Advisory Committee | 0.486251 |
| risk-assessed passengers | 0.461206 |
| rabies risk assessment | 0.629931 |
| maintenance crew members | 0.456115 |
| flight crew members | 0.519016 |
| public health | 0.967835 |
| human rabies cases | 0.555506 |
| separate risk assessment | 0.442692 |
| aircraft cabin | 0.476689 |
| flight attendant | 0.460263 |
| bat droppings | 0.448496 |
| rabies vaccination history | 0.568233 |
| ground crew members | 0.95456 |
| postexposure rabies | 0.549147 |
|
CLICK HERE |
| 7684 |
Centers for Disease Control and Prevention |
Html |
en |
Collegiate Leaders in Environmental Health (CLEH) - 2011 Intern Profiles |
CDC Collegiate Leaders in Environmental Health - 2011 Intern Profiles |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 8810 |
Centers for Disease Control and Prevention |
Html |
en |
Naegleria fowleri - Images of Naegleria fowleri |
Information for health professionals about Naegleria fowleri. Education and information about the brain eating ameba Naegleria fowleri that causes encephalitis and death including frequently asked questions, biology, sources of infection, diagnosis, treatment, prevention and control, and other publications and pertinent information for the public and medical professionals. |
| large numbers | 0.352042 |
| arrows | 0.310526 |
| section | 0.329492 |
| videos | 0.310923 |
| photos | 0.310137 |
| characteristic nuclear morphology | 0.400604 |
| shipping instructions | 0.364528 |
| large cluster | 0.350598 |
| CDC Emergency Operations | 0.41789 |
| real-time | 0.3108 |
| cerebral portion | 0.414138 |
| wet mount | 0.357582 |
| contact | 0.311015 |
| specimen collection guidance | 0.416747 |
| magnification | 0.43167 |
| phase contrast microscopy | 0.40793 |
| lymphocytes | 0.316101 |
| Higher magnification | 0.396906 |
| Extensive hemorrhage | 0.414053 |
| eosin | 0.318795 |
| Focal hemorrhage | 0.419633 |
| viewers | 0.310654 |
| laboratory diagnosis | 0.419395 |
| photographs | 0.310917 |
| Naegleria fowleri trophozoites | 0.96664 |
|
| exciter filter | 0.355814 |
| large clusters | 0.354855 |
| 24/7 | 0.311057 |
| increased speed | 0.359511 |
| primary amebic meningoencephalitis | 0.418066 |
| Inset | 0.313369 |
| capillaries | 0.313385 |
| PAM patient | 0.467978 |
| treatment recommendations | 0.362499 |
| microscope | 0.323216 |
| frontal cortex | 0.499044 |
| Clinicians | 0.311632 |
| variety | 0.310119 |
| CSF | 0.338105 |
| cysts | 0.328578 |
| brain tissue architecture | 0.402336 |
| Naegleria fowleri trophozoite | 0.645375 |
| polymorphonuclear leukocytes | 0.362375 |
| Center | 0.310998 |
| fluorescent antibody | 0.358053 |
| nucleus | 0.311602 |
| necrosis | 0.351242 |
| diagnostic assistance | 0.364662 |
| anti-Naegleria fowleri antibody | 0.52538 |
|
CLICK HERE |
| 10522 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: September 10, 2012'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| CDC | 0.79773 |
| Salmonella Braenderup Infections | 0.571051 |
| annual National Preparedness | 0.606126 |
| Public Health Matters | 0.583523 |
| Emergency Preparedness | 0.598236 |
| FDA Safety Information | 0.57715 |
| Nile virus infections | 0.634162 |
| Yosemite National Park | 0.66796 |
| Health Alert Network | 0.578176 |
| CDC Health Advisory | 0.694817 |
| Nile Virus epidemiology | 0.616115 |
| – (CDC) | 0.655555 |
| CDC Science Clips | 0.698141 |
| Additional COCA Conference | 0.595771 |
| Disaster Risk Reduction | 0.576483 |
| state health departments | 0.581669 |
| Cases Sparks Concern | 0.564288 |
| CDC Influenza Division | 0.683735 |
| important safety information | 0.576599 |
| Nile virus exposures | 0.612749 |
| new pharmacy-focused effort | 0.579183 |
| health care providers | 0.58037 |
| Free CE credit/contact | 0.573398 |
| Weekly Flu View | 0.569555 |
| human medical products | 0.566437 |
|
| EID Home Page | 0.574117 |
| preparedness resources | 0.57051 |
| Current Travel Warnings | 0.568746 |
| blood pressure control | 0.579004 |
| CDC Features | 0.704494 |
| Event Reporting Program | 0.567234 |
| CDC Fact Sheet | 0.679327 |
| Human Infections Reported | 0.571355 |
| U.S. Preventive Services | 0.573578 |
| COCA Email Update | 0.600308 |
| west nile virus | 0.920741 |
| public health community | 0.593401 |
| public health | 0.605379 |
| Specific Hazards preparedness | 0.596447 |
| Nile virus season | 0.613649 |
| preparedness message | 0.565239 |
| subject matter expert | 0.577923 |
| in-person training centers | 0.570527 |
| Hantavirus Pulmonary Syndrome | 0.570954 |
| National Park Hantavirus | 0.583021 |
| National Park Service | 0.578412 |
| high blood pressure | 0.578754 |
| weekly influenza surveillance | 0.568507 |
| Response Training Resources | 0.577353 |
|
CLICK HERE |
| 12859 |
Centers for Disease Control and Prevention |
Html |
en |
Community Quarantine to Interrupt Ebola Virus Transmission -Mawah Village, Bong County, Liberia, August-October, 2014 |
Tolbert Nyenswah, MPH1*, David J. Blackley, DrPH2*, Tabeh Freeman, MD3, Kim A. Lindblade, PhD4, Samson K. |
| proposed measures | 0.331293 |
| Ebola treatment unit | 0.719852 |
| effective community quarantine | 0.464312 |
| household quarantine | 0.375545 |
| public health interventions | 0.33475 |
| David J. Blackley | 0.455998 |
| Ebola virus transmission | 0.450766 |
| community quarantine period | 0.45128 |
| local river crossings | 0.338485 |
| District Ebola Task | 0.543899 |
| ebola task force | 0.629186 |
| Community quarantine measures | 0.471749 |
| Ebola virus | 0.642779 |
| Cara N. Halldin | 0.339067 |
| task force | 0.931559 |
| new Ebola infection | 0.50979 |
| Samson K. Arzoaquoi | 0.336608 |
| Bong Mine Town | 0.537512 |
| A. Scott Laney | 0.340222 |
| Kim A. Lindblade | 0.336165 |
| district health authorities | 0.335642 |
| Task Force chair | 0.363628 |
| county health officer | 0.475714 |
| 7Fuamah District Health | 0.3354 |
| basic medical services | 0.328589 |
|
| adult male Mawah | 0.354368 |
| Ebola virus disease | 0.512541 |
| Mawah | 0.440178 |
| community members | 0.352579 |
| local leaders | 0.463164 |
| Ebola virus testing | 0.480503 |
| quarantine period | 0.471664 |
| MMWR
Tolbert Nyenswah | 0.338853 |
| community leaders | 0.387203 |
| Justin N. Williams | 0.334744 |
| Ebola cases | 0.432715 |
| community quarantine | 0.749014 |
| source patient | 0.435976 |
| Bong County | 0.563065 |
| Mawah leaders | 0.334453 |
| Bong County health | 0.467446 |
| village | 0.348184 |
| Global Health Protection | 0.405034 |
| county Ebola task | 0.570095 |
| current Ebola epidemic | 0.44757 |
| medical care | 0.391865 |
| Ebola response | 0.407546 |
| probable Ebola | 0.408713 |
| county health team | 0.388483 |
|
CLICK HERE |
| 13587 |
Centers for Disease Control and Prevention |
Html |
en |
Licensure of a Diphtheria and Tetanus Toxoids and AcellularPertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidancefor Use as a Booster Dose |
Jennifer Liang, DVM1; Greg Wallace, MD2; Gina Mootrey, DO1. |
| Sanofi Pasteur Inc. | 0.60069 |
| earlier dose | 0.466012 |
| Jennifer Liang | 0.433219 |
| American Academy | 0.483367 |
| Gina Mootrey | 0.277979 |
| ACIP liaison organizations | 0.503602 |
| final dose | 0.587873 |
| inactivated poliovirus types | 0.37654 |
| Greg Wallace | 0.267219 |
| inactivated poliovirus | 0.427721 |
| valid final dose | 0.576267 |
| children | 0.274994 |
| U.S. children | 0.260898 |
| Family Physicians | 0.260769 |
| National Center | 0.343805 |
| deltoid muscle | 0.261695 |
| acellular pertussis | 0.324313 |
| Pediatric Nurse Practitioners | 0.375363 |
| dose | 0.83338 |
| pertussis toxoid | 0.288351 |
| tetanus toxoids | 0.446046 |
| Respiratory Diseases | 0.343133 |
| individual antigens | 0.299634 |
| filamentous hemagglutinin | 0.261819 |
| previous dose | 0.458966 |
|
| VAR vaccines | 0.323438 |
| DTaP-IPV vaccine formulations | 0.572339 |
| minimum interval requirements | 0.371769 |
| separately administered DTaP | 0.482677 |
| United States | 0.274652 |
| Quadracel vaccine | 0.771617 |
| Drug Administration | 0.273774 |
| Immunization Practices | 0.282079 |
| Advisory Committee | 0.262389 |
| additional combined diphtheria | 0.432724 |
| previous doses | 0.264563 |
| DTaP vaccines | 0.426642 |
| federal Vaccines | 0.334089 |
| Sanofi Pasteur | 0.995075 |
| DTaP vaccine | 0.441562 |
| IPV series | 0.564063 |
| ACIP Combination Vaccines | 0.579423 |
| National Association | 0.259188 |
| DTaP-IPV vaccine | 0.596732 |
| vaccine | 0.863897 |
| licensed indications | 0.263679 |
| DTaP series | 0.302148 |
| Children Program | 0.265834 |
| work group | 0.415801 |
|
CLICK HERE |